drugset / Trial / NCT00171496

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

NCT00171496

Phase 4 Completed 693 enrolled Novartis
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the impact of tacrolimus and cyclosporine microemulsion on glucose metabolism in kidney transplant recipients and the efficacy and safety in preventing organ rejection

Timeline

Start
2003-10
Primary completion
2006-03
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Comparator Tacrolimus Small molecule

Indications

No indication recorded.